Gonorrhea Update.
This article provides a brief summary of recent US epide-miology, antimicrobial resistance, and treatment of Neisseria gonorrhoeae infections. Selected research regarding infections caused by N. gonorrhoeae is described, with particular emphasis on the advances made by new molecular methods.
Bash
Margaret C.
MC
Division of Bacterial, Parasitic, and Allergenic Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, HFM-428, 1401 Rockville Pike, Rockville, MD 20852, USA. bash@cber.fda.gov